Filing Details
- Accession Number:
- 0001179110-21-004535
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-21 16:09:37
- Reporting Period:
- 2021-04-19
- Accepted Time:
- 2021-04-21 16:09:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1808968 | B. Matthew Klein | C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-04-19 | 859 | $48.17 | 18,450 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-04-20 | 1,444 | $46.58 | 17,006 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-04-20 | 197 | $47.92 | 16,809 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,500 RSUs from a April 16, 2020 grant of 10,000 RSUs.
- This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 10, 2021.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $46.24 to $47.06 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.68 to $48.17 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
